Browsing by Subject "Screening"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Development of a planar yeast estrogen screen as screening tool for estrogen active compounds
    (2018) Schick, Dinah; Schwack, Wolfgang
    Substances that disrupt or impair the hormone system (endocrine system) or that show an irreversible influence on it are referred to as endocrine disruptors or xenohormones. Concerning this, also estrogen active compounds (EAC) are endocrine disruptors, that are under suspicion of being involved in the formation of tumors or to induce disruption during development and reproduction, and are, for example, blamed for being responsible for the feminization of fish. At this, EAC can be natural (human, phytoestrogens) but also synthetic substances, which are discharged to the environment by humans (e.g. pharmaceuticals, pesticides, additives). Regarding the ubiquitous presence of EAC, suitable methods for the analysis of EAC are required. An in vitro method for the determination of EAC is the YES assay (yeast estrogen screen) that is executed in liquid solutions in microtiter plates and that works with genetically modified yeasts, which contain the human estrogen receptor (hER) and a reporter gene encoding for the enzyme beta-galactosidase. In presence of EAC, the enzyme is produced and subsequently cleaves a substrate that is used to measure the receptor activity and thus the estrogenic activity. The transfer of the YES assay to high-performance thin-layer chromatography (HPTLC) was successfully demonstrated and advanced, thus resulting in the combination of a chromatographic separation of analytes and the detection of EAC using genetically modified yeast cells directly on the HPTLC plate (HPTLC planar yeast estrogen screen, HPTLC-pYES). Usually, the substrate 4-methylumbelliferyl-beta-D-galactopyranoside is used for pYES, releasing blue fluorescing 4-methylumbelliferone (MU) after enzymatic cleavage. Various matrices, however, often contain a plenty of different components, partly showing native fluorescences (blue, red), why the detection of the blue fluorescing MU can be interfered. By applying the substrate resorufin-beta-D-galactopyranoside (RGP) and by using automated devices, the RGP-pYES as fast screening tool for EAC was developed and successfully applied to waste water samples and extracts of hops pellet samples. A screening method using HPTLC simultaneously represents a planar clean-up, why samples do not have to undergo complex steps of sample preparation or purification. The chromatographic separation in combination with the detection of estrogenic activity using genetically modified yeasts directly on the plate allowed the detection, the determination and the identification of single EAC. Using RGP, which releases orange fluorescing resorufin after enzymatic cleavage as positive signal of estrogenic activity, enabled a clear differentiation between fluorescences due to estrogenicity and the native fluorescence of sample components. Application of the RGP-pYES to spiked water samples and sewage samples showed high recovery rates and a good precision, and thus the applicability of the method as screening tool for environmental samples. By means of suitable evaluation methods, additionally the generation of dose-response curves of known and unknown EAC and thus the generation of so-called logit-log plots was possible. This enabled the determination of estradiol equivalent factors of known EAC as well as the determination of estradiol equivalent concentrations and amounts, respectively, of known and unknown EAC in liquid and solid samples. Thus, the possibility to estimate the estrogenic potential of a sample or single sample components was given. The coupling of pYES to mass spectrometry additionally allowed the identification of unknown EAC, demonstrated exemplarily by investigation of extracts of hops pellet samples, in which the only detected EAC in the hops extracts was identified as prenylnaringenin. Since the method uses a planar system, the pYES advantageously reveals all chromatographically separated sample components at one look and, as bioassay, additionally detects a possible estrogenic activity (activity at the hER) of single substances, while a differentiation between native occurring fluorescences of sample contaminants and the fluorescence as positive signal for estrogenicity of a substance is granted.
  • Thumbnail Image
    Publication
    Inflammation and nutrition: friend or foe?
    (2023) Stumpf, Franziska; Keller, Bettina; Gressies, Carla; Schuetz, Philipp
    The importance of the interplay between inflammation and nutrition has generated much interest in recent times. Inflammation has been identified as a key driver for disease-related malnutrition, leading to anorexia, reduced food intake, muscle catabolism, and insulin resistance, which are stimulating a catabolic state. Interesting recent data suggest that inflammation also modulates the response to nutritional treatment. Studies have demonstrated that patients with high inflammation show no response to nutritional interventions, while patients with lower levels of inflammation do. This may explain the contradictory results of nutritional trials to date. Several studies of heterogeneous patient populations, or in the critically ill or advanced cancer patients, have not found significant benefits on clinical outcome. Vice versa, several dietary patterns and nutrients with pro- or anti-inflammatory properties have been identified, demonstrating that nutrition influences inflammation. Within this review, we summarize and discuss recent advances in both the role of inflammation in malnutrition and the effect of nutrition on inflammation.